City Therapeutics Other 8-K Filing
City Therapeutics filed its amended and restated certificate of incorporation and bylaws in connection with the completion of its initial public offering. The amendments authorize 500 million shares of common stock and 10 million shares of undesignated preferred stock while eliminating stockholder action by written consent. These administrative changes are standard corporate governance updates triggered by the company's transition to a public entity.